Abstract:Interleukin-10 (IL-10) is an immunomodulatory cytokine that plays a pivotal role in the pathogenesis of acute coronary syndromes (ACS). Here, we evaluated the role of IL10 promoter variants as markers for ACS susceptibility in Western Mexican patients as well as its association with IL10 mRNA and IL-10 plasma levels. Three promoter variants (− 1082 A > G, − 819 T > C and − 592 A > C) were analyzed in 300 ACS patients and 300 control group (CG) individuals. IL10 relative gene expression was evaluated in peripheral blood mononuclear cells (PBMC) and IL-10 levels were quantified in plasma. The allelic, genotypic and haplotypic frequencies did not show significant differences between groups. ACS patients had sevenfold higher mRNA IL10 level compared to CG (p = 0.0013). Homozygous C/C carriers in both − 819 T > C and − 592 A > C variants had 0.4-fold higher IL10 mRNA expression than heterozygous and polymorphic allele homozygous genotypes (p = 0.0357) in ACS group. There were significant differences in plasma IL-10 levels in CG and ACS group (1.001 vs 1.777 pg/mL, p = 0.0051). The variants were not markers of susceptibility to ACS in Western Mexican individuals. ACS patients showed higher IL10 expression than CG individuals which could be mediated by − 819 T > C and − 592 A > C variants and pharmacotherapy.

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the following aspects: 1. **Evaluating the role of IL10 promoter variants as markers of susceptibility to acute coronary syndrome (ACS)** - The researchers analyzed whether three variants (−1082 A > G, −819 T > C and −592 A > C) located in the promoter region of the IL10 gene were associated with the susceptibility to ACS in Western Mexican patients. 2. **Analyzing the association between promoter single - nucleotide variants (SNVs) and IL10 mRNA levels** - The researchers explored whether these promoter variants affected the expression level of the IL10 gene. 3. **Evaluating IL - 10 plasma levels in ACS patients** - The researchers measured the IL - 10 plasma levels in ACS patients and control individuals and compared the differences between the two groups. ### Specific research background and objectives - **The role of IL - 10** - IL - 10 is an important immunomodulatory cytokine that plays a protective role in the formation, development, and stabilization of atherosclerotic plaques. It may reduce the risk of ACS by inhibiting the inflammatory response and reducing the progression of atherosclerosis. - **Research subjects** - The researchers selected 300 ACS patients and 300 control individuals and analyzed their IL10 promoter variants, IL10 mRNA levels, and IL - 10 plasma levels. - **Main hypothesis** - The researchers hypothesized that IL10 promoter variants might affect the expression level of IL10, thereby affecting the susceptibility to ACS. However, they also hoped to prove through experiments whether these variants were really related to the susceptibility to ACS. ### Research methods - **Genetic analysis** - The researchers used the Hardy - Weinberg equilibrium test (HWE) to analyze the allele and genotype frequencies of each variant. - Through linkage disequilibrium (LD) analysis, the researchers evaluated the relationships between these variants and determined the main haplotypes. - **Gene expression analysis** - Using the 2−ΔΔCq method, the researchers compared the relative IL10 mRNA expression levels between ACS patients and control individuals. - They further analyzed the IL10 mRNA expression levels in patients with different clinical manifestations (unstable angina UA, ST - segment elevation myocardial infarction STEMI, and non - ST - segment elevation myocardial infarction NSTEMI). - **Plasma IL - 10 level determination** - The researchers determined the IL - 10 plasma levels in ACS patients and control individuals and carried out statistical analysis. ### Main findings - **Relationship between genetic variants and ACS susceptibility** - The research results showed that these IL10 promoter variants were not markers of ACS susceptibility in the Western Mexican population. There were no significant differences in allele, genotype, and haplotype frequencies between the two groups. - **IL10 mRNA expression levels** - The IL10 mRNA expression level in ACS patients was significantly higher than that in the control group (seven - fold). In particular, ACS patients with the homozygous (C/C) genotype of the −819 T > C and −592 A > C variants had an IL10 mRNA expression level 0.4 - fold higher than that of individuals with heterozygous and polymorphic allele homozygous genotypes. - **IL - 10 plasma levels** - The IL - 10 plasma level in ACS patients was significantly higher than that in the control group (1.777 pg/mL vs 1.001 pg/mL). However, there were no significant differences in IL - 10 plasma levels among ACS patients with different clinical manifestations. ### Conclusions - **Main conclusions** - This study found that IL10 promoter variants (−1082 A > G, −819 T > C and −592 A > C) were not markers of ACS susceptibility in the Western Mexican population. - The IL10 mRNA expression level in ACS patients was significantly higher than that in the control group, which might be due to the influence of the −819 T > C and −592 A > C variants and the result of drug treatment. - The IL - 10 plasma level was significantly increased in ACS patients, but different...

IL10 promoter variants are associated with gene expression but they are not markers of susceptibility to acute coronary syndrome

Association of Polymorphisms in the IL‐10 Promoter Region with Crohn's Disease

Downregulation of TIGIT Expression in FOXP3+Regulatory T Cells in Acute Coronary Syndrome

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

IL-10 Polymorphism is Associated with Increased Incidence of Severe Sepsis.

Interleukin 10.G Microsatellite in the Promoter Region of the Interleukin-10 Gene in Severe Sepsis

Interleukin-10 Promoter Gene Polymorphisms and Susceptibility to Tuberculosis: A Meta-Analysis

Genetic polymorphism within the interleukin10 gene promoter in patients with severe sepsis

Interleukin-8 Gene Polymorphism Is Associated With Acute Coronary Syndrome In The Chinese Han Population

Association of IL-1 Gene Complex Members with Ankylosing Spondylitis in Chinese Han Population.

Association between endothelial nitric oxide synthase gene polymorphism (-786T>C) and interleukin-6 in acute coronary syndrome

Major Adverse Cardiovascular Events: The Importance of Serum Levels and Haplotypes of the Anti-Inflammatory Cytokine Interleukin 10

IL10 rs1800872 Is Associated with Non-Steroidal Anti-Inflammatory Drugs Exacerbated Respiratory Disease in Mexican-Mestizo Patients

Polymorphisms on chromosome 9p21 confer a risk for acute coronary syndrome in a Chinese Han population.

Interleukin 6 polymorphisms are associated with cardiovascular risk factors in premature coronary artery disease patients and healthy controls of the GEA Mexican study

Association Between Three Interleukin-10 Gene Polymorphisms and Coronary Artery Disease Risk: a Meta-Analysis.

Association of Interleukin-10 Gene -592 A/C Polymorphism with the Clinical and Pathological Diversity of Lupus Nephritis.

Association of Interleukin-10 Promoter Polymorphisms and Corresponding Plasma Levels with Susceptibility to Laryngeal Squamous Cell Carcinoma

Associations of the CYP7A1 Gene Polymorphisms Located in the Promoter and Enhancer Regions with the Risk of Acute Coronary Syndrome, Plasma Cholesterol, and the Incidence of Diabetes

Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: A systematic review and meta-analysis

Impact of IL-10 gene promoter polymorphisms on treatment response in HCV patients: A systematic review, a meta-analysis, and a meta-regression